PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

316 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
41.
Klimek, L.* et al.: In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan-An EAACI position paper. Allergy 75, 2161-2169 (2020)
42.
Lemonnier, N.* et al.: A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents. Allergy 75, 3248-3260 (2020)
43.
Matricardi, P.M.* et al.: The role of mobile health technologies in allergy care: An EAACI position paper. Allergy 75, 259-272 (2020)
44.
Palomares, O.* et al.: Biologicals in allergic diseases and asthma: Toward personalized medicine and precision health: Highlights of the 3rd EAACI Master Class on Biologicals, San Lorenzo de El Escorial, Madrid, 2019. Allergy 75, 936-940 (2020)
45.
Pfaar, O.* et al.: Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas—An EAACI Task Force Report. Allergy 75, 1099-1106 (2020)
46.
Pfaar, O.* et al.: COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper. Allergy 76, 648-676 (2020)
47.
Radzikowska, U.* et al.: Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 75, 2829-2845 (2020)
48.
Riggioni, C.* et al.: A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy 75, 2503-2541 (2020)
49.
Sokolowska, M.* et al.: Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy 75, 2445-2476 (2020)
50.
Stein, K.* ; Zissler, U.M. ; Schmidt-Weber, C.B. & Heine, H.*: How airway epithelial cells direct dendritic cells in asthma: A search for master regulators. Allergy 75, 168-169 (2020)
51.
Thyssen, J.P.* et al.: Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis. Allergy 75, 1481-1485 (2020)
52.
Till, S.J.* ; Sonne Stage, B.* ; Skypala, I.* & Biedermann, T.: Potential treatment effect of the SQ tree sublingual immunotherapy-tablet on pollen food syndrome caused by apple. Allergy 75, 2059-2135 (2020)
53.
Wolff, P.T.* et al.: High prevalence of wheeze and atopy in rural Malagasy children. Allergy, DOI: 10.1111/all.14303 (2020)
54.
Agache, I.* et al.: Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases. Allergy 74, 2064-2076 (2019)
56.
Boonpiyathad, T.* et al.: Impact of high-altitude therapy on type-2 immune responses in asthma patients. Allergy 75, 84-94 (2019)
57.
Breiteneder, H.* et al.: Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care. Allergy 74, 2293-2311 (2019)
58.
Candeias, J. ; Schmidt-Weber, C.B. & Buters, J.T.M.: An in vitro exposure chamber for whole pollen at the air-liquid-interface. Allergy 74, 622-622 (2019)
59.
Damialis, A. et al.: Evaluating the real exposure of allergics to airborne pollen: Too high, too early, too long or too complex? Allergy 74, 42-42 (2019)
60.
de los Reyes Jimenez, M. et al.: Modulation of the myeloid arachidonic acid metabolism imparts helminth-driven control of type 2 inflammation. Allergy 74, 112-112 (2019)